These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 21483937)

  • 1. A cell-based biosensor for real-time detection of cardiotoxicity using lensfree imaging.
    Kim SB; Bae H; Cha JM; Moon SJ; Dokmeci MR; Cropek DM; Khademhosseini A
    Lab Chip; 2011 May; 11(10):1801-7. PubMed ID: 21483937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening, verification, and analysis of biomarkers for drug-induced cardiac toxicity in vitro based on RTCA coupled with PCR Array technology.
    Zhang L; Xu MX; Yin QS; Zhu CY; Cheng XL; Ren YR; Zhuang PW; Zhang YJ
    Toxicol Lett; 2017 Feb; 268():17-25. PubMed ID: 28099878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Embryonic stem cell-derived cardiomyocytes as a model system to study cardioprotective effects of dexamethasone in doxorubicin cardiotoxicity.
    Farokhpour M; Karbalaie K; Tanhaei S; Nematollahi M; Etebari M; Sadeghi HM; Nasr-Esfahani MH; Baharvand H
    Toxicol In Vitro; 2009 Oct; 23(7):1422-8. PubMed ID: 19596060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of doxorubicin toxicity on cardiomyocytes using a dual functional extracellular biochip.
    Xiao L; Hu Z; Zhang W; Wu C; Yu H; Wang P
    Biosens Bioelectron; 2010 Dec; 26(4):1493-9. PubMed ID: 20732805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assaying cardiac biomarkers for toxicity testing using biosensing and cardiomyocytes derived from human embryonic stem cells.
    Andersson H; Steel D; Asp J; Dahlenborg K; Jonsson M; Jeppsson A; Lindahl A; Kågedal B; Sartipy P; Mandenius CF
    J Biotechnol; 2010 Oct; 150(1):175-81. PubMed ID: 20633583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug response analysis for scaffold-free cardiac constructs fabricated using bio-3D printer.
    Arai K; Murata D; Takao S; Nakamura A; Itoh M; Kitsuka T; Nakayama K
    Sci Rep; 2020 Jun; 10(1):8972. PubMed ID: 32487993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of dexamethasone administration on the protection against doxorubicin-induced cardiotoxicity in purified embryonic stem cell-derived cardiomyocytes.
    Dehghani L; Farokhpour M; Karbalaie K; Nematollahi M; Tanhaie S; Hayati-Rodbari N; Kiani-Esfahani A; Hescheler J; Nasr-Esfahani MH; Baharvand H
    Tissue Cell; 2013 Apr; 45(2):101-6. PubMed ID: 23141520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An optical multi-sensing system for detection of cardiovascular toxicity.
    Koo KI; Kim SB; Kim K; Oh J
    Biotechnol Lett; 2014 May; 36(5):1089-94. PubMed ID: 24563288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Manipulation-free cultures of human iPSC-derived cardiomyocytes offer a novel screening method for cardiotoxicity.
    Rajasingh S; Isai DG; Samanta S; Zhou ZG; Dawn B; Kinsey WH; Czirok A; Rajasingh J
    Acta Pharmacol Sin; 2018 Oct; 39(10):1590-1603. PubMed ID: 29620051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Embryonic stem cells as a novel cell source of cell-based biosensors.
    Liu Q; Huang H; Cai H; Xu Y; Li Y; Li R; Wang P
    Biosens Bioelectron; 2007 Jan; 22(6):810-5. PubMed ID: 16621504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of genomic biomarkers for anthracycline-induced cardiotoxicity in human iPSC-derived cardiomyocytes: an in vitro repeated exposure toxicity approach for safety assessment.
    Chaudhari U; Nemade H; Wagh V; Gaspar JA; Ellis JK; Srinivasan SP; Spitkovski D; Nguemo F; Louisse J; Bremer S; Hescheler J; Keun HC; Hengstler JG; Sachinidis A
    Arch Toxicol; 2016 Nov; 90(11):2763-2777. PubMed ID: 26537877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of field potential as a marker of embryonic stem cell-derived cardiomyocytes, and endpoint analysis of embryonic stem cell test.
    Koseki N; Deguchi J; Yamada T; Funabashi H; Seki T
    J Toxicol Sci; 2010 Dec; 35(6):899-909. PubMed ID: 21139340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-induced functional cardiotoxicity screening in stem cell-derived human and mouse cardiomyocytes: effects of reference compounds.
    Himmel HM
    J Pharmacol Toxicol Methods; 2013; 68(1):97-111. PubMed ID: 23702537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The protective effect of cardiac gene transfer of CuZn-sod in comparison with the cardioprotector monohydroxyethylrutoside against doxorubicin-induced cardiotoxicity in cultured cells.
    Abou El Hassan MA; Heijn M; Rabelink MJ; van der Vijgh WJ; Bast A; Hoeben RC
    Cancer Gene Ther; 2003 Apr; 10(4):270-7. PubMed ID: 12679799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel purification method of murine embryonic stem cell- and human-induced pluripotent stem cell-derived cardiomyocytes by simple manual dissociation.
    Shinozawa T; Furukawa H; Sato E; Takami K
    J Biomol Screen; 2012 Jun; 17(5):683-91. PubMed ID: 22274911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A non-invasive platform for functional characterization of stem-cell-derived cardiomyocytes with applications in cardiotoxicity testing.
    Maddah M; Heidmann JD; Mandegar MA; Walker CD; Bolouki S; Conklin BR; Loewke KE
    Stem Cell Reports; 2015 Apr; 4(4):621-31. PubMed ID: 25801505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem cell derived in vivo-like human cardiac bodies in a microfluidic device for toxicity testing by beating frequency imaging.
    Bergström G; Christoffersson J; Schwanke K; Zweigerdt R; Mandenius CF
    Lab Chip; 2015 Aug; 15(15):3242-9. PubMed ID: 26135270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxorubicin triggers bioenergetic failure and p53 activation in mouse stem cell-derived cardiomyocytes.
    Cunha-Oliveira T; Ferreira LL; Coelho AR; Deus CM; Oliveira PJ
    Toxicol Appl Pharmacol; 2018 Jun; 348():1-13. PubMed ID: 29653124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiotoxicity screening of illicit drugs and new psychoactive substances (NPS) in human iPSC-derived cardiomyocytes using microelectrode array (MEA) recordings.
    Zwartsen A; de Korte T; Nacken P; de Lange DW; Westerink RHS; Hondebrink L
    J Mol Cell Cardiol; 2019 Nov; 136():102-112. PubMed ID: 31526813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and evaluation of next-generation cardiotoxicity assay based on embryonic stem cell-derived cardiomyocytes.
    Ryu B; Choi SW; Lee SG; Jeong YH; Kim U; Kim J; Jung CR; Chung HM; Park JH; Kim CY
    BMB Rep; 2020 Aug; 53(8):437-441. PubMed ID: 32336319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.